Urology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yamakado K et al. - The combination therapy described is a safe multidisciplinary therapeutic option that can lengthen survival among patients with adrenal metastasis from hepatocellular carcinoma.

Related Articles

Pedunculated hepatocellular carcinoma and splenic metastasis
World Journal of Gastroenterology, 11/13/09    Relevance Score: 66%

Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index
Supportive Care in Cancer, 11/19/09    Relevance Score: 46%

Bilateral adrenal gland enlargement secondary to histoplasmosis mimicking adrenal metastases: Diagnosis with EUS-guided FNA
Diagnostic Cytopathology, 11/11/09    Relevance Score: 46%

The role of PET in the surgical approach to adrenal disease
European Journal of Surgical Oncology, 10/19/09    Relevance Score: 46%

Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis
Cancer Chemotherapy and Pharmacology, 10/15/09    Relevance Score: 45%

Today in Adrenal Glands...keeping you current

Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma
Journal of Clinical Endocrinology and Metabolism, 12/17/09

Ultrasound-assisted Microsurgery for Cushing's Disease
Experimental and Clinical Endocrinology & Diabetes, 12/17/09

Diagnosis and Treatment of Adrenal Tumors: A Single-Center Experience with 238 Cases
Urologia Internationalis, 12/17/09